Featured image for “RNID and GN Hearing Partner to Improve Theatre Accessibility with Auracast”
Oct. 14, 2026

RNID and GN Hearing Partner to Improve Theatre Accessibility with Auracast

HHTM
LONDON, UK — RNID and GN Hearing have announced the launch of Auracast for Theatres, a new practical guide designed to help theatres and live-performance venues improve audio accessibility for people who are deaf or have hearing loss. Developed by RNID, the UK charity supporting people who are deaf, have hearing loss or tinnitus, with support from GN Hearing, the playbook
Featured image for “Can Sound Preference Influence Hearing Aid Adoption? New WSA Studies Suggest It Can”
Oct. 13, 2026

Can Sound Preference Influence Hearing Aid Adoption? New WSA Studies Suggest It Can

HHTM
LYNGE, DENMARK – WSA has announced results from two clinical studies suggesting that incorporating individual sound preferences into hearing aid consultations may increase the likelihood that patients proceed with hearing aid purchases. Conducted across 42 hearing care clinics in Spain, Canada, and the United States, the studies involved more than 3,000 clients and found that hearing aid conversion rates were approximately
Featured image for “Audiologists and Vaccines: Preparing for the Resurgence of Vaccine-Preventable Hearing Loss”
Oct. 12, 2026

Audiologists and Vaccines: Preparing for the Resurgence of Vaccine-Preventable Hearing Loss

HHTM
Today, HHTM posts what is believed to be the final article of Dr. Jerry Northern, co-authored with Barry Freeman. We honor Dr. Northern as a collaborative pioneer in pediatric audiology and list the influential textbooks he co-authored or co-edited. Hearing in Children (1974; 6th edition, 2014) Co-authored with Marion P. Downs Hearing Disorders (1976; later editions, 3rd edition, 1996) Clinical
Featured image for “Widex Allure AI Review: Building on Natural Sound with On-Demand AI”
Oct. 12, 2026

Widex Allure AI Review: Building on Natural Sound with On-Demand AI

HHTM
Widex has built much of its reputation around natural sound quality, low processing delay, and an approach to hearing aid technology that aims to preserve the listening experience rather than heavily alter it. With the introduction of the new Widex Allure AI RIC hearing aids, the company is expanding that philosophy to address one of the most persistent challenges for
Featured image for “Sonorous Neurovascular Receives FDA Authorization for Pulsatile Tinnitus Stent Trial”
Oct. 11, 2026

Sonorous Neurovascular Receives FDA Authorization for Pulsatile Tinnitus Stent Trial

HHTM
LAKE FOREST, CALIFORNIA — Sonorous Neurovascular has received authorization from the U.S. Food and Drug Administration (FDA) to begin a pivotal clinical trial evaluating its investigational BosSTENT™ device for the treatment of pulsatile tinnitus associated with cerebral venous sinus stenosis. The FDA approved the company’s Investigational Device Exemption (IDE) on October 2, 2026, allowing Sonorous to initiate B-SILENT 2, a
Featured image for “Why Detailed Hearing Tests May Be Key to Understanding Genetic Hearing Loss Risk”
Oct. 09, 2026

Why Detailed Hearing Tests May Be Key to Understanding Genetic Hearing Loss Risk

HHTM
NASHVILLE, TENNESSEE — Researchers at Vanderbilt University Medical Center have found that combining genetic information with detailed hearing test results may improve the ability to identify genetic factors associated with hearing loss, potentially opening the door to earlier detection and more personalized hearing healthcare. The study, published October 8, 2026, in JAMA Otolaryngology–Head & Neck Surgery, found that using audiometric
Featured image for “Does Your Marketing Reflect Person-Centered Care?”
Oct. 09, 2026

Does Your Marketing Reflect Person-Centered Care?

HHTM
Hearing aid advertising doesn’t often resonate with me. Smiling seniors on a sunny porch, often without a hearing aid in sight. What does that have to do with following a meeting at work or a conversation in a loud restaurant? Most product categories want you to see the merchandise and understand how it is used. Hearing aids are the exception.
Featured image for “Cilcare Taps Hearing Industry Veteran Kevin Franck to Lead North American Expansion”
Oct. 08, 2026

Cilcare Taps Hearing Industry Veteran Kevin Franck to Lead North American Expansion

HHTM
BOSTON, MA — Cilcare, a biotechnology company focused on auditory science, has appointed Kevin Franck, PhD, MBA, as Head of US and General Manager, North America. Based in Washington, DC, Franck will oversee the company’s North American growth strategy, including efforts to expand partnerships involving its clinical research and development platforms. Franck brings more than 25 years of experience spanning
Featured image for “We Value Hearing — So Why Is Hearing Loss Still So Misunderstood?”
Oct. 07, 2026

We Value Hearing — So Why Is Hearing Loss Still So Misunderstood?

HHTM
Nearly half (48%) of U.S. adults say society doesn’t know enough about hearing loss — even though people overwhelmingly recognize the importance of good hearing. In this conversation, Shari Eberts speaks with Dr. Patrick D’Haese, Corporate Director of Awareness and Public Affairs at MED-EL, about findings from a new international survey of more than 10,000 adults across 10 countries. The
Featured image for “Auditdata Adds NAL-NL3 and Oldenburg Matrix Test to Measure Clinical Platform”
Oct. 07, 2026

Auditdata Adds NAL-NL3 and Oldenburg Matrix Test to Measure Clinical Platform

HHTM
COPENHAGEN, DENMARK — Auditdata has added two independent hearing-care tools to its Measure™ clinical software platform, bringing the new NAL-NL3 hearing aid fitting system and the Oldenburg Matrix Sentence Test into a single clinical workflow. The additions connect two important parts of hearing care: selecting evidence-based hearing aid fitting targets and evaluating how well a patient can understand speech in